Cas:866417-21-2 6-Amino-7-fluoro-3-oxo-3,4-dihydro-2-quinoxalinecarboxylic acid manufacturer & supplier

Chemical Name:6-Amino-7-fluoro-3-oxo-3,4-dihydro-2-quinoxalinecarboxylic acid

CAS.NO:866417-21-2

Synonyms:6-Amino-7-fluoro-3-oxo-3,4-dihydro-2-quinoxalinecarboxylic acid

Molecular Formula:C₉H₆FN₃O₃

Molecular Weight:223.16100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:109.07000

Exact Mass:223.03900

LogP:0.92380

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6-Amino-7-fluoro-3-oxo-3,4-dihydro-2-quinoxalinecarboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Amino-7-fluoro-3-oxo-3,4-dihydro-2-quinoxalinecarboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Amino-7-fluoro-3-oxo-3,4-dihydro-2-quinoxalinecarboxylic acid Use and application,6-Amino-7-fluoro-3-oxo-3,4-dihydro-2-quinoxalinecarboxylic acid technical grade,usp/ep/jp grade.

Related News: US citizens who have been to China in the last 14 days need to re-book to one of seven gateway airports: John F. Kennedy International Airport in New York, Los Angeles International Airport, Seattle, San Francisco International Airport, Chicago, Atlanta and Honolulu. 6-Amino-7-fluoro-3-oxo-3,4-dihydro-2-quinoxalinecarboxylic acid manufacturer Delta said it will suspend flights between the United States and China starting on Sunday until at least April 30, according to a press release. 6-Amino-7-fluoro-3-oxo-3,4-dihydro-2-quinoxalinecarboxylic acid supplier The government is leveraging its large patient population to push non-domestic drugs companies to cut prices to their lowest level globally. 6-Amino-7-fluoro-3-oxo-3,4-dihydro-2-quinoxalinecarboxylic acid vendor Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development. 6-Amino-7-fluoro-3-oxo-3,4-dihydro-2-quinoxalinecarboxylic acid factory The government is leveraging its large patient population to push non-domestic drugs companies to cut prices to their lowest level globally.